癌痛管理解决方案市场基础(关键地区、市场参与者、规模和份额)-到 2031 年的预测

  • Report Code : TIPRE00022897
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Cancer Pain Management Solutions Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市场概述随着全球患者经历的中度至重度疼痛模式的发展,癌痛管理解决方案市场预计将获得显着的推动力。在全球平台上,近70%的癌症患者可能因脊髓损伤而遭受慢性疼痛,28%因多发性硬化症,8%因中风。除此之外,预计超过 75% 的患者会抱怨随着疾病的进展,疼痛逐渐加剧。因此,经历此类疼痛的患者数量的增加可能会对市场的增长产生积极影响。此外,随着研究和开发重点的提高,可能会有一系列药物正在研发中。预计这对全球癌症疼痛管理市场来说是个好兆头,因为更多的药物可能会增加需求。 市场范围 “到2031年全球癌痛管理解决方案市场分析”是对制药行业的专业深入研究,特别关注全球市场趋势分析。该报告旨在概述癌症疼痛管理解决方案市场,并按疼痛管理类型、治疗类型、疾病适应症、最终用途和地理位置进行详细的市场细分。该报告提供了领先的癌症疼痛管理解决方案市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。 市场细分
    • 根据疼痛管理类型,全球癌症疼痛管理解决方案市场分为急性疼痛管理、中度疼痛管理和重度疼痛管理。 • 根据治疗类型,市场分为药物、设备或系统。药物又细分为阿片类药物/麻醉剂、非阿片类药物和神经阻滞,设备又细分为电刺激设备、镇痛输液泵、神经刺激设备和射频消融设备。 • 根据疾病适应症,市场分为肺癌、结直肠癌、乳腺癌、前列腺癌、血癌等。 • 根据最终用途,市场分为医院、诊所和其他。
市场动态 驱动因素
    • 全球癌症发病率上升。 • 人们对癌症及其疼痛管理的认识不断提高。 • 医疗保健支出增加,政府减少癌症的举措增加 • 老年人口激增
限制
    • 与使用癌症止痛药相关的副作用是这个市场的主要制约因素。
该报告提供了该行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的全球市场的概述和预测。它还提供了 2021 年至 2031 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲。每个地区的癌症疼痛管理解决方案市场随后按各自的国家和细分市场进行细分。该报告涵盖了全球18个国家以及该地区当前趋势和机遇的分析和预测。报告从需求和供给两个方面分析了影响市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:在评估了北美、欧洲、亚太地区、中东和非洲和南美洲影响这些地区癌症疼痛管理解决方案市场的政治、经济、社会和技术因素后。 COVID-19 对癌症疼痛管理解决方案市场的影响COVID-19 于 2021 年 12 月首次在中国武汉爆发,此后在全球范围内快速传播。从确诊病例和死亡人数来看,美国、印度、巴西、俄罗斯、法国、英国、土耳其、意大利和西班牙是受影响最严重的国家。由于封锁、旅行禁令和企业关闭,COVID-19 一直在影响各国的经济和行业。各种工厂和工厂的关闭影响了全球供应链,并对全球市场产品的制造、交货时间表和销售产生了负面影响。很少有公司已经宣布可能推迟产品交付以及未来产品销量的下滑。除此之外,欧洲、亚太和北美国家实施的全球旅行禁令正在影响业务合作和伙伴关系机会。 市场参与者 该报告涵盖了癌症疼痛管理解决方案市场作为有机和无机增长战略的主要发展。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上出现的无机增长战略活动包括收购、伙伴关系和合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对癌症疼痛管理解决方案的需求不断增长,癌症疼痛管理解决方案市场的市场支付者预计未来将获得利润丰厚的增长机会。该报告还包括主要公司的概况及其在癌症疼痛管理解决方案市场中的 SWOT 分析和市场策略。此外,该报告重点关注领先的行业参与者,提供公司简介、所提供的组件和服务、过去三年的财务信息、过去五年的关键发展等信息。
    •Teva Pharmaceutical Industries Ltd. •Eli Lilly。 • 辉瑞公司 • 强生公司 • 普渡制药公司 • 远藤制药公司。 • 森林实验室公司。 • 葛兰素史克公司。 • F。 Hoffmann-La Roche Ltd. • Baxter International Inc.
Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,具有先进的统计专业知识,并在现有研究中提供各种定制选项。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. Eli Lilly.
3. Pfizer
4. Johnson & Johnson
5. Purdue Pharma
6. Endo Pharmaceuticals Plc.
7. Forest Laboratories Inc.
8. GlaxoSmithKline Plc.
9. F. Hoffmann-La Roche Ltd.
10. Baxter International Inc.
11. Valeant Pharmaceuticals International Inc.
12. Daiichi Sankyo Co., Ltd
13. Grnenthal Pharma GmbH & Co. KG
14. Hisamitsu Pharmaceutical Co., Inc
15. Insys Therapeutics, Inc
16. Mundipharma International Limited
17. Orexo AB
18. Aoxing Pharmaceutical Company, Inc
19. BioDelivery Sciences International, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..